Roswell Park study: Targeting the E3 ligase activity of MDM2 could help control p53 protein

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers from Roswell Park Comprehensive Cancer Center uncovered a previously unknown function of a gene that regulates the p53 protein, mutations of which have been linked to a wide variety of cancers.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

When conducting a randomized clinical trial of a treatment regimen based on an immune checkpoint inhibitor, trial sponsors should include overall survival as an endpoint, FDA officials say.

Login